Evista

In a statement, Eli Lilly said it was pleased with the rulings, but that it will review its legal options regarding the ruling on the longer-term Evista patents.

Court Backs Injunction Blocking Generic Versions of Lilly's Evista 2010

However, both drugs increase blood clots and stroke risks relative to placebo, and Evista is not as good as Tamoxifen in preventing DCIS.

Menopause News Round-Up aka TBTAM 2007

The Food and Drug Administration has approved two pills to prevent breast cancer in older women or those at high risk: tamoxifen, a standard of breast cancer therapy, and raloxifene, also known as Evista, commonly used to treat osteoporosis.

Few women taking breast cancer prevention drugs 2011

The Food and Drug Administration has approved two pills to prevent breast cancer in older women or those at high risk: tamoxifen, a standard of breast cancer therapy, and raloxifene, also known as Evista, commonly used to treat osteoporosis.

Few women taking breast cancer prevention drugs 2011

Bazedoxifene is a selective estrogen receptor modulator, or SERM, the same category as Eli Lilly & Co.'s Evista, which is approved to prevent and treat osteoporosis.

Pfizer Set to Seek Aprela Nod Peter Loftus 2012

Raloxifene, an estrogen alternative introduced by Eli Lilly in 1997 under the brand name Evista, reduces the risk not only of fractures but of breast cancer.

Reconsidering Hrt 2007

Both bisphosphonates, like Fosamax, Actonel, and Boniva, and raloxifene Evista, which is a selective estrogen receptor modulator or SERM, have been approved by the Food and Drug Administration to prevent bone loss and fractures.

Our Bodies, Ourselves: Menopause M.D. Vivian Pinn 2006

Both bisphosphonates, like Fosamax, Actonel, and Boniva, and raloxifene Evista, which is a selective estrogen receptor modulator or SERM, have been approved by the Food and Drug Administration to prevent bone loss and fractures.

Our Bodies, Ourselves: Menopause M.D. Vivian Pinn 2006

As of April 2006, raloxifene which is sold under the brand name Evista had not been federally approved for use in preventing breast cancer.

Our Bodies, Ourselves: Menopause M.D. Vivian Pinn 2006

As of April 2006, raloxifene which is sold under the brand name Evista had not been federally approved for use in preventing breast cancer.

Our Bodies, Ourselves: Menopause M.D. Vivian Pinn 2006